Bandit Biosystems, Inc. began operations on December 11, 2025. The company acquired the qPCR and NGS product assets previously developed by SeqOnce Biosciences, Inc., and continues to develop, manufacture and support research-use-only multiplex qPCR panels, amplification master mixes and RhinoSeq™ NGS library preparation kits.
What stays the same for customers
- Products. The multiplex qPCR panels, positive controls and master mixes laboratories already run.
- Catalog numbers. Existing part numbers carry over.
- Support. Molecular biologists who help with setup, verification and troubleshooting.
- U.S. manufacturing. Products are made and shipped from U.S. facilities.
What we offer
- Multiplex qPCR and RT-qPCR panels for women's health and sexually transmitted pathogens, urinary tract, wound and antibiotic resistance, respiratory and emerging-pathogen targets.
- Amplification master mixes matched to each panel.
- RhinoSeq™ DNA library preparation for Illumina sequencing.
- Custom assay development and OEM supply for laboratories and partners.
Bandit Biosystems, Inc. and SeqOnce Biosciences, Inc. are separate companies. Posts originally published by SeqOnce Biosciences are kept in our news archive for reference.